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Abstract
Matrix-assisted laser-desorption/ionization time-of-ﬂight (MALDI-TOF) is positioned at the forefront of bacterial identiﬁcation in the
future. Its performance needed to be evaluated in a routine Bacteriology laboratory to determine its true beneﬁts. A prospective study
was carried out in the Bacteriology laboratory of the Pellegrin University Hospital in Bordeaux, France, from April to May 2009. Bacte-
rial isolates from clinical samples were identiﬁed by conventional phenotypic bacteriological methods [Phoenix (Becton-Dickinson) or
API strips (bioMe´rieux)] and in parallel with a mass spectrometer (Ultraﬂex III TOF/TOF and the BIOTYPER database from Bruker Dalton-
ics). In case of a discrepancy between these results at the genus level, a 16S rRNA and/or rpoB gene sequencing was performed. Of the
1013 bacteria tested, 837 (82.6%) were correctly identiﬁed at the species level by MALDI-TOF mass spectrometry (MS) without extrac-
tion and 189 after extraction, i.e. 986 (97.3%) were correctly identiﬁed at the species level by MALDI-TOF MS, vs. 945 (93.2%) by phe-
notypic methods. Indeed, the extraction step was necessary for only 15% of the isolates. These results were even better when
considering the genus, reaching almost 99% with MALDI-TOF MS and 98% with phenotypic methods. The performance of MALDI-TOF
MS is very attractive considering its efﬁciency and rapidity, and the technique constitutes a precious tool for bacteriological identiﬁcation
in a routine laboratory.
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Introduction
Bacterial identiﬁcation is still essentially based on methods
developed at the end of the 19th Century by Koch, Pasteur
and others. Recent progress, however, has led to automated
techniques and, furthermore, molecular methods are becom-
ing more popular. All of these routine methods allow a bac-
teriological identiﬁcation within 8–24 h or more, which is
quite long for urgent cases where antibiotherapy has to be
established and adapted based on the species identiﬁcation.
Mass spectrometry (MS) was proposed for bacterial identiﬁ-
cation a long time ago [1], but only recently has progress
been made allowing it to become a promising technique
using matrix-assisted laser-desorption/ionization time-of-ﬂight
(MALDI-TOF) MS. Currently, MS is being used to determine
bacteriological identiﬁcation, based on the protein proﬁle of
each species of bacteria [2]. Good results have been
obtained in different studies [3,4]. The present study aimed
to use the simplest MALDI-TOF protocol to evaluate its
accuracy in routine practice in a large University hospital in
comparison with standard methods.
Materials and Methods
Bacterial isolates
One thousand and thirteen different isolates obtained in the
Laboratory of Bacteriology at Pellegrin Hospital in Bordeaux,
France, were included from April to May 2009. A large vari-
ety of clinical specimens were issued from the respiratory
tract, ear, nose, throat, urine, biopsies, blood, pus, stools
genital tract, and other diverse material, from which the bac-
teria were isolated at three of the six benches in our labora-
tory. Five people were involved in the study and participated
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in the technical steps. Each clinical specimen was plated on
an adequate agar plate (e.g. Bromocresol Purple lactose agar,
Columbia agar + 5% sheep blood, Chocolate agar + Polyvitex,
Columbia agar + 5% sheep blood and nalidixic acid; all from
bioMe´rieux, Marcy l’Etoile, France), depending on the sample
and in accordance with the recommendations of our own
laboratory procedures. Each plate was incubated for 24 or
48 h in an aerobic, microaerobic or anaerobic atmosphere.
In total, 624 Gram-negative rods, 366 Gram-positive cocci,
20 Gram-positive rods and three Gram-negative cocci were
included. The detection of mycobacteria did not form part of
our study because those identiﬁcation tests are performed in
a special laboratory. The present study also excluded Cam-
pylobacter sp. identiﬁcation because our laboratory is the
National Reference Center for Campylobacter and Helicobact-
er and a speciﬁc study was performed in parallel.
Phenotypic identiﬁcation(s)
All of the bacteria isolated were identiﬁed using appropriate
Phoenix galleries with the Phoenix automated microbiology
system (Becton-Dickinson Diagnostics, Le Pont-De-Claix,
France) depending on microscopic examination, including
Gram staining, and catalase and oxidase activities. API strips
(bioMe´rieux) were used for fastidious bacteria and anaerobic
bacteria, and sometimes when the percentage of identiﬁca-
tion using the Phoenix system was <99%.
MS identiﬁcation
Preparation of samples. A colony of each isolate directly
issued from the primary agar plate was deposited on an MTP
384 target plate ground steel T F (Bruker Daltonics, Bremen,
Germany) in a unique replicate and allowed to dry at room
temperature, except for the Gram-positive cocci, which
were deposited in two replicates: one before extraction and
one after extraction. Each isolate was analyzed on the day of
isolation. When the extraction protocol was perfomed, the
manufacturer’s recommendations were followed. Brieﬂy, one
colony was suspended in 300 lL of distilled water; 900 lL of
ethanol was added and mixed. Then, the sample was centri-
fuged, the supernatant removed, and the pellets dried. Fifty
microlitres of formic acid (70% in water) were added to the
bacterial pellet; the components were mixed thoroughly, and
50 lL of acetonitrile was added. After centrifugation
(13 000 g for 2 min), 1 lL of the supernatant containing the
bacterial extract was transferred onto the target plate. In
addition to the colony or the bacterial extract deposited,
1 lL of matrix solution (satured solution of a cyano-4-
hydroxycinnamic acid in 50% acetonitrile) was added and
was then crystallized by air-drying at room temperature for
5 min.
Measurements with the spectrometer. Measurements were per-
formed with an Ultraﬂex III TOF/TOF mass spectrometer
(Bruker Daltonics) equipped with a 200-Hz smart-beam 1
laser. The parameter settings were: delay: 80 ns; ion source:
1 voltage, 25 kV, ion source: 2 voltage, 23.4 kV; lens voltage:
6 kV; mass range: 0–20 137 kDa. Each run was validated with
an Escherichia coli control sample provided by Bruker Dalton-
ics where the presence of eight speciﬁc proteins insured that
the spectrometer was set properly. Raw spectra of the strains
were analyzed by MALDI BIOTYPER 2.0 software (Bruker Dal-
tonics) using the default settings (all of the settings are poten-
tially adjustable). The whole process from MALDI-TOF MS
measurement to identiﬁcation was performed automatically
without any user intervention. Brieﬂy, the software generated
a list of peaks up to 100. The threshold for peak acceptance
was a signal-to-noise ratio of 3. After alignment, peaks with a
mass-to-charge ratio difference of <250 p.p.m. were consid-
ered to be identical. The peak lists generated were used for
matches against the reference library, by directly using the
integrated pattern matching algorithm of the software. All
parameters were the same, regardless of the bacteria ana-
lyzed. Spectra were obtained in the positive linear mode after
1000 shots (size, 61 794 points; delay, 232 points). A score
was attributed to each identiﬁcation obtained by MALDI-TOF
MS. When this score was >2.00, identiﬁcation was considered
correct at the species level; in the range 1.7–1.999, the identi-
ﬁcation was considered correct at the genus level; and <1.7,
the identiﬁcation was not similar enough to a spectrum to
draw a conclusion. For bacteria other than Gram-positive
cocci, when the score was <2.0, an extraction step was car-
ried out and the extract was tested again.
Genotypic identiﬁcation
16S rRNA gene sequencing [5,6] was performed as
previously reported [7]. rpoB gene sequencing was also
performed for Staphylococcus species [8]. The ampliﬁed
primer-less sequences were compared with the GenBank
database with the BLAST software at the National Center for
Biotechnology Information computer server [9] (http://blast.
ncbi.nlm.nih.gov/Blast.cgi) and the species identiﬁcation was
conﬁrmed using the bioinformatics bacterial identiﬁcation
tool BIBI [10].
Identiﬁcation was considered to be correct when there
was a concordance between the identiﬁcation found with the
MALDI-TOF MS and that of current phenotypic methods.
For discordant results at the species level, identiﬁcations
were considered to be correct with MALDI-TOF MS if the
score was >2. For discordant results at the genus level, 16S
rDNA sequencing was performed and the molecular biology
result was considered as the reference.
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Results
MALDI-TOF MS identiﬁcation
Of 1013 isolates (Fig. 1), 837 were identiﬁed at the species
level (with score values ‡2) without extraction. For 176 iso-
lates, an extraction step was performed. Among these, 149
isolates were identiﬁed at the species level (with score val-
ues ‡2); 16 were identiﬁed at the genus level (with score val-
ues in the range 1.7–1.999); seven isolates remained
unidentiﬁed (score value <1.7); and four isolates were falsely
identiﬁed (with score values ‡2). Among the 16 isolates not
identiﬁed by MALDI-TOF MS (Table 1), four Acinetobacter
baumannii were identiﬁed as Acinetobacter sp., and one Acinet-
obacter johnsonii as Acinetobacter lwofﬁi. Among the other
strains, eight were correctly identiﬁed with the MALDI-TOF
MS but with a score <2, in the range 1.789–1.976 (i.e. very
close to 2). For two of these eight isolates, the phenotypic
identiﬁcation was not concordant either with sequencing at
the species level. Lastly, the MALDI-TOF MS gave four false
identiﬁcations: Haemophilus salivarius was identiﬁed as Strepto-
coccus salivarius, Bordetella parapertussis was identiﬁed as
Bordetella bronchiseptica, Citrobacter freundii was identiﬁed as
Pseudomonas aeruginosa, and Streptococcus australis was identi-
ﬁed as Streptococcus parasanguinis by sequencing and Strep-
tococcus mitis by phenotypic methods. With MALDI-TOF
MS, four isolates were incorrectly identiﬁed at the genus
level and a further seven isolates were not identiﬁed at all,
for a total of 11 unidentiﬁed or wrongly identiﬁed isolates.
Among these 11 isolates, four were identiﬁed at the species
level with phenotypic methods: Haemophilus aphrophilus,
P. aeruginosa, Streptococcus pneumoniae and Clostridium
ramosum.
Phenotypic identiﬁcation
With regard to standard phenotypic methods, an identiﬁca-
tion was obtained for 1006 out of 1013 bacteria. Nine hun-
dred and forty-ﬁve (93.2%) were correctly identiﬁed at the
species level and 996 cases (98.4%) at the genus level. With
regard to identiﬁcation at the species level, the phenotypic
methods failed for 52 isolates (5.13%). Among the most com-
mon errors, ten were coagulase negative staphylococci, six
were Pseudomonas sp. and two were Aeromonas sp. for which
the species were not well identiﬁed. Twelve Enterobacteria-
ceae and ﬁve Corynebacteria sp. were not correctly identiﬁed
either. However, for the majority of the cases (35/52), stan-
dard methods were able to identify the correct genus. For
17 isolates, phenotypic methods failed concerning identiﬁca-
tion at the genus level; more precisely, they led to a false
identiﬁcation for ten isolates and, for the other seven iso-
lates, no identiﬁcation at all was found (Table 2). Among
these 17 isolates, ten were correctly identiﬁed by MALDI-
TOF MS.
Discussion
This large study based on MS, performed as part of routine
laboratory identiﬁcation, led to the several observations, as
outlined below.
Deposit step
A single deposit was made per isolate and this may have neg-
atively inﬂuenced the MALDI-TOF results. However, we
considered that it was more valuable in terms of time and
even cost to make a single deposit for routine diagnosis.
1013 isolates
Concordance at the genus level
n = 989
Discordance at the genus level
n = 24
Genus correct with routine tests
but incorrect with MALDI-TOF
n = 7
Genus correct with MALDI-TOF
but incorrect with routine tests
n = 12
Correct identification with
sequencing only
n = 5
Concordance between MALDI-TOF and routine
tests at the species level
n = 921
Species correct 
with routine tests
but incorrect
with MALDI-TOF
n = 14
Species correct 
with MALDI-TOF
but incorrect 
with routine tests
n = 52
Exact identification with
sequencing only
n = 2
FIG. 1. Bacterial identiﬁcation obtained
with the different methods. MALDI-TOF
MS, matrix-assisted laser-desorption/ion-
ization time-of-ﬂight mass spectrometry.
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Because excellent results were obtained, we consider that
our deliberate choice was valid.
Extraction step
This step, which is without a doubt time-consuming, does
not appear to be necessary in routine testing; only 15% of
the isolates required an extraction. Among the 149 bacterial
isolates for which an extraction was needed to achieve a
score >2, the initial score was indeed very close to two for
the majority (see Supporting information, Table S1). Finally,
we consider that this step should not be performed
routinely.
Discrepant results between MALDI-TOF and phenotypic
methods
Errors with the phenotypic methods. As previously shown, the
errors found with current phenotypic methods were gener-
ally at the species level because the genus was frequently
correct. The percentage of errors found in Phoenix in the
present study was similar to those found in various studies,
in the range 83.9–99.3%, depending on the bacteria studied
and methods used for the reference identiﬁcation [11–13].
However, for all the Gram-positive cocci, the species deter-
mination remains quite difﬁcult because neither the Phoenix,
nor the API strips can lead to an identiﬁcation with certainty,
given that the scores obtained are not very high and that
several identiﬁcations are often proposed. For these bacterial
isolates, the identiﬁcation is quite long, taking more than
24 h and sometimes requiring molecular methods. There-
fore, the use of MALDI-TOF MS is of particular interest for
such isolates with respect to obtaining a quicker result and a
lower cost compared to current methods. Moreover, the
TABLE 1. Unvalidated results of
bacterial identiﬁcation at the spe-
cies or genus level using matrix-
assisted laser-desorption/ionization
time-of-ﬂight mass spectrometry
(MALDI-TOF MS) after extraction
vs. phenotypic methods
MALDI-TOF MS (score)
Routine phenotypic
methods
16S rRNA gene
sequencing
Isolates identiﬁed at the genus level
Escherichia coli (1.975) E. coli NT
Acinetobacter sp. (2.228) Acinetobacter baumannii NT
Streptococcus parasanguinis (1.912) Streptococcus mitis Streptococcus australis
Acinetobacter sp. (2.175) Acinetobacter baumannii NT
Staphylococcus saprophyticus (1.907) S. saprophyticus NT
Streptococcus pyogenes (1.897) S. pyogenes NT
Bordetella bronchiseptica (2.02) Bordetella parapertussis Bordetella parapertussis
E. coli (1.896) E. coli NT
Acinetobacter lwofﬁi (2.312) NI Acinetobacter johnsonii
Staphylococcus saprophyticus (1.764) S. saprophyticus NT
Acinetobacter sp. (2.136) A. baumannii NT
Moraxella catarrhalis (1.901) Moraxella catarrhalis NT
Enterococcus faecalis (1.976) E. faecalis NT
Acinetobacter sp. (2.308) A. baumannii NT
Streptococcus pneumoniae (1.789) S. pneumoniae NT
Pseudomonas stutzeri (1.715) Pseudomonas oryzihabitans P. stutzeri
Isolates with an erroneous identiﬁcation
Corynebacterium jeikeium (2.098) NI Lactobacillus rhamnosus
Lactobacillus gasseri (2.139) Streptococcus sp. Propionibacterium acnes
Streptococcus salivarius (2.017) Haemophilus aphrophilus H. aphrophilus
Citrobacter freundii (2.093) Pseudomonas aeruginosa P. aeruginosa
Isolates for which no identiﬁcation was found
NI NI Catenibacterium mutsuoka
NI S. pneumoniae S. pneumoniae
NI Clostridium ramosum C. ramosum*
NI Corynebacterium striatum Corynebacterium phocae
NI Bacteroides stercoris NT
NI Corynebacteria sp. P. acnes
NI Sphingobacterium sp. Chryseobacterium sp.*
NI, not identiﬁed; NT, not tested.
*Species not present in the database.
TABLE 2. Discrepancies observed for bacterial identiﬁcation
at the genus level using phenotypic methods vs. matrix-
assisted laser-desorption/ionization time-of-ﬂight mass spec-
trometry (MALDI-TOF MS) and 16S rRNA gene sequencing
Phenotypic
methods MALDI-TOF MS (score)
16S rRNA gene
sequencing
Sphingobacterium sp. NI Chryseobacterium sp.*
Corynebacteria sp. NI Propionibacterium acnes
Streptococcus sp. Lactobacillus gasseri (2.139) P. acnes
Neisseria lactamica Gardnerella vaginalis (2.382) G. vaginalis
NI Aggregatibacter aphrophilus (2.05) A. aphrophilus
Corynebacteria sp. Biﬁdobacterium breve (2.148) B. breve
Gemella morbillorum Neisseria bacilliformis (2.023) N. bacilliformis
Gemella haemolysans Corynebacterium striatum (2.291) NT
Gemella haemolysans Staphylococcus saccharolyticus
(2.013)
S. saccharolyticus
Kocuria varians Turicella otitidis (2.015) NT
Corynebacteria sp. P. acnes (2.03) NT
NI Dermobacter hominis (2.02) D. hominis
NI Bacillus subtilis (2.017) B. subtilis
NI Neisseria elongata (2.011) N. elongata
NI Corynebacterium jeikeium (2.098) Lactobacillus rhamnosus
NI Acinetobacter lwofﬁi (2.312) Acinetobacter johnsonii
NI NI Catenibacterium mutsuoka
NI, not identiﬁed; NT, not tested.
*Species not present in the database.
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strains for which MALDI-TOF MS and sequencing results
matched were bacteria that are usually difﬁcult to identify
with standard methods as a result of fastidious growth or
because of speciﬁc incubation conditions (e.g. anaerobic
atmosphere) [14]. This technique is undoubtedly of great
help to identify rare species [15], or bacteria whose growth
is difﬁcult but which are present in the database. [16].
Errors with the MALDI-TOF MS. Different discrepancies can
occur: (i) lack of identiﬁcation at the species level and (ii)
‘real’ errors.
Using MALDI-TOF MS, in four cases, A. baumannii was
identiﬁed only at the genus level as Acinetobacter sp. Similarly,
for two strains of S. pneumoniae, one was identiﬁed with a
very low score (1.789) and the other was not identiﬁed at
all, whereas a result was obtained with phenotypic methods.
There is no clear explanation for for this lack of success,
except that there is such an important diversity in these spe-
cies that the spectrum obtained does not always match
those of the database. Moreover, for Acinetobacter sp., the
failure may also be a result of the current limitations of Aci-
netobacter taxonomy (i.e. different taxa are grouped under
the name A. baumannii).
Another problem with the MALDI-TOF MS was the low
score obtained for eight bacterial isolates, even after extrac-
tion (Table 1). However, another parameter can be used as
an identiﬁcation criterion, which is the number of matching
proﬁles corresponding to a given species. Indeed, for each
species, several spectra corresponding to the same bacterial
species are present in the Bruker Daltonics BIOTYPER data-
base. Therefore, another possibility for validating the species
identiﬁcation would be to consider the number of times that
the spectrum matches the bacterium under study. If this cri-
terion had been used, these eight bacterial isolates would
have been identiﬁed with the MALDI-TOF MS. This consti-
tutes an interesting method for obtaininh a correct species
identiﬁcation and this approach would again shorten the
identiﬁcation process. Finally, MALDI-TOF MS is very accu-
rate, more so than our usual methods to identify bacterial
isolates [17].
Limitations as a result of the database
The main problem of the MALDI-TOF MS is the database
which still needs to be expanded. Some isolates were not
identiﬁed by MALDI-TOF MS because they are absent from
the Bruker Daltonics database or they are present in insufﬁ-
cient numbers. Concerning anaerobic bacteria, the MALDI-
TOF MS failed in a certain number of cases. These two
points have been addressed in previous studies [4] indicating
a weakness in the technique. This is problematic because
anaerobic bacteria are difﬁcult to identify under routine con-
ditions and a solution via MALDI-TOF MS would be very
welcome in this domain. Nevertheless, other studies have
shown that, with an adapted database, the MALDI-TOF MS
is of great interest for identifying anaerobic species within a
short time [16]. Thus, all of these problems can be solved by
adding more species and more isolates of the same species
to the database.
Lastly, one major limit with the MALDI-TOF MS is the
lack of information on antimicrobial susceptibility. There is
certainly room for improvement here, again after having
enlarged the Bruker Daltonics database. Indeed, the creation
of sub-databases (e.g. to discriminate between methicillin-
resistant and methicillin-susceptible S. aureus) should be feasi-
ble because their protein proﬁles are different [18,19], as
well as there being the possibility of determining the resis-
tance proﬁle of different Enterobacteriaceae [20].
Integration of a spectrometer in laboratory routine
MS is undoubtedly the future tool of a bacteriology labora-
tory but its use in routine laboratory procedures will change
work habits. To optimize its use and to give faster results
concerning bacterial identiﬁcation, ideally during agar plate
reading, each colony suspected of medical interest (based on
macroscopic and microscopic morphology) could be depos-
ited on a target plate as a unique sample. After reading all of
the plates, it would be possible to obtain identiﬁcation of all
bacteria collected and deposited on the target plate within
30–40 min for approximately 50 different strains. Ultimately,
the bacteria for which susceptibility testing is necessary
would be selected. Money would therefore be saved because
antibiogram galleries, especially those with liquid medium,
are quite expensive. Time would be saved, especially in com-
parison with phenotypic identiﬁcation that requires a mini-
mum of 24 h for the majority of isolates. Using
spectrometry in such a way would constitute a real revolu-
tion in the standard bacteriology laboratory.
Conclusions
The present study, which evaluated the MS for routine iden-
tiﬁcation of bacteria, showed that: (i) the extraction step is
not necessary to obtain the greater majority of identiﬁca-
tions, allowing one to save time and (ii) the number of spec-
trum matches can be used when the score is >1.7 and <2.
Moreover, we evaluated the concordance of identiﬁcation
obtained with phenotypic methods vs. MALDI-TOF MS on
more than 1000 isolates issued from clinical specimens,
showing that: (i) the MALDI-TOF MS appears better than
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our routine methods for bacterial identiﬁcation and (ii) a
better concordance was observed with sequencing than phe-
notypic methods.
The present study did not evaluate the cost of identiﬁca-
tion criterion, which has been considered positively in other
studies.
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